With regard to other clinical tests, the STRONG-HF study reported that patients had lower mean concentrations of NTproBNP at screening (7110.7 ng/L) and at baseline (4025.6 ng/L) [5] than the HEROES population (at admission 9015 pg/mL). Here, NPPB is linked to hydrops fetalis.